What Is the Role of Public Health in the Era of GLP-1 Receptor Agonists

被引：0
|
作者：
Moore, Justin B. [1 ]
机构：
[1] Wake Forest Univ, Div Publ Hlth Sci, Dept Implementat Sci, Bowman Gray Sch Med, 525 Vine St, Winston Salem, NC 27101 USA
来源：
JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE | 2024年 / 30卷 / 06期
关键词：
D O I：
10.1097/PHH.0000000000002064
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：775 / 776
页数：2
相关论文
共 50 条
  • [41] Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists
    Ghosh, Puja
    Fontanella, Rosaria Anna
    Scisciola, Lucia
    Pesapane, Ada
    Taktaz, Fatemeh
    Franzese, Martina
    Puocci, Armando
    Ceriello, Antonio
    Prattichizzo, Francesco
    Rizzo, Maria Rosaria
    Paolisso, Giuseppe
    Barbieri, Michelangela
    THERANOSTICS, 2023, 13 (14): : 4872 - 4884
  • [42] GLP-1 Receptor Agonists and Cardiac Health: Insights from a Systematic Review
    Pedrosa, Mauricio Reis
    da Silva, Arnaldo Alves
    Trevisani, Virginia Fernandes Moca
    CARDIOVASCULAR DRUGS AND THERAPY, 2025,
  • [43] The role of GLP-1 receptor agonists in managing type 2 diabetes br
    Nachawi, Noura
    Rao, Pratibha P. R.
    Makin, Vinni
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2022, 89 (08) : 457 - 464
  • [44] GLP-1 RECEPTOR VARIANTS MARKEDLY DIFFERENTIATE GLYCAEMIC RESPONSE TO GLP-1 RECEPTOR AGONISTS: A DIRECT STUDY
    Dawed, A. Y.
    Mari, A.
    McDonald, T. J.
    Hong, M. -G
    Sharma, S.
    Robertson, N. R.
    Mahajan, A.
    Walker, M.
    Gough, S.
    Zhou, K.
    Forgie, I
    Ruetten, H.
    Jones, A. G.
    Pearson, E. R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 13 - 14
  • [45] GLP-1 receptor variants markedly differentiate glycaemic response to GLP-1 receptor agonists: a DIRECT study
    Dawed, A. Y.
    Mari, A.
    McDonald, T. J.
    Hong, M. G.
    Sharma, S.
    Robertson, N. R.
    Mahajan, A.
    Walker, M.
    Gough, S.
    Zhou, K.
    Forgie, I.
    Ruetten, H.
    Jones, A. G.
    Pearson, E. R.
    DIABETOLOGIA, 2017, 60 : S393 - S393
  • [46] Metabolic Syndrome and the Role of GLP-1 Receptor Agonists in a Model of Postmenopausal PCOS
    Fernandez, Edgar D. Torres
    Romero, Damian G.
    Cardozo, Licy L. Yanes
    FASEB JOURNAL, 2018, 32 (01):
  • [47] Predicting the response to GLP-1 receptor agonists: an unexpected role for β-arrestin-1
    Sladek, Robert
    LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (01): : 3 - 4
  • [48] The Effect of GLP-1 Receptor Agonists on Bowel Preparation
    Mahmood, Sabah
    Ozminkowski, Erin
    Sakiri, Ahmet
    Aqeel, Ammar
    Abbasi, Abu Fahad
    Andersen, William
    Zhan, Weihai
    Khan, Naser
    Hamoudah, Thayer
    Dawood, Altaf
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S360 - S361
  • [49] GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
    Bezin, Julien
    Gouverneur, Amandine
    Penichon, Marine
    Mathieu, Clement
    Garrel, Renaud
    Hillaire-Buys, Dominique
    Pariente, Antoine
    Faillie, Jean-Luc
    DIABETES CARE, 2023, 46 (02) : 384 - 390
  • [50] Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists
    Alhiary, Rasha
    Kesselheim, Aaron S.
    Gabriele, Sarah
    Beall, Reed F.
    Tu, S. Sean
    Feldman, William B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (07): : 650 - 657
12345